Olwen Hahn to Ki-67 Antigen
This is a "connection" page, showing publications Olwen Hahn has written about Ki-67 Antigen.
Connection Strength
0.058
-
Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial. JAMA Oncol. 2024 Mar 01; 10(3):362-371.
Score: 0.058